Skip to Content

J 105 (Tolterodine Tartrate Extended-Release 4 mg)

Pill with imprint J 105 is Blue, Capsule-shape and has been identified as Tolterodine Tartrate Extended-Release 4 mg. It is supplied by Camber Pharmaceuticals, Inc..

Tolterodine is used in the treatment of urinary incontinence; urinary frequency and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Tolterodine 4 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 105

Tolterodine tartrate extended-release 4 mg J 105

Tolterodine Tartrate Extended-Release

Imprint
J 105
Strength
4 mg
Color
Blue
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Camber Pharmaceuticals, Inc.
Manufacturer
Hetero Labs Limited
National Drug Code (NDC)
31722-0608
Inactive Ingredients
calcium phosphate dibasic anhydrous, FD&C Blue No. 2, hypromelloses, gelatin, methylene chloride, microcrystalline cellulose, magnesium silicate, titanium dioxide, butyl alcohol, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, ethylcelluloses, alcohol, methyl methacrylate, ammonia

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.